Immune Design Reports First Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- CAE agrees to sell Flightscape unit to SITA for $500 million
Cowen Starts Immune Design (IMDZ) at Outperform
May 15, 2015 7:04 AM EDTCowen initiated coverage on Immune Design (NASDAQ: IMDZ) with an Outperform rating.
For an analyst ratings summary and ratings history on Immune Design click here. For more ratings news on Immune Design click here.
Shares of Immune Design closed at $21.29 yesterday.
... MoreImmune Design (IMDZ) Tops Q1 EPS by 8c
May 14, 2015 7:00 AM EDTImmune Design (NASDAQ: IMDZ) reported Q1 EPS of ($0.56), $0.08 better than the analyst estimate of ($0.64). Revenue for the quarter came in at $1.9 million versus the consensus estimate of $1.3 million.
For earnings history and earnings-related data on Immune Design (IMDZ) click here.
... More


